<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04783831</url>
  </required_header>
  <id_info>
    <org_study_id>ARQUIMEDES</org_study_id>
    <nct_id>NCT04783831</nct_id>
  </id_info>
  <brief_title>Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy</brief_title>
  <official_title>Usefulness of Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy. Prospective Non-randomized Controlled Clinical Study Comparing Biodegradable vs Non-biodegradable Stents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Virgen de la Arrixaca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Virgen de la Arrixaca</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: postoperative pancreatic fistula (POPF) remains the most important morbidity&#xD;
      after pancreaticoduodenectomy (PD). There is no consensual technique for pancreatic&#xD;
      reconstruction and many surgeons use a transanastomotic drain. Currently, the stents used are&#xD;
      not degradable and they can cause obstruction, stricture and pancreatitis. The use of&#xD;
      biodegradable stents that disappear a few months after the intervention could have a role in&#xD;
      the prevention of pancreaticojejunostomy complications.&#xD;
&#xD;
      Material and method: A single-center prospective randomized study was planned with patients&#xD;
      undergoing PD. A duct-to-mucosa end-to-side anastomosis is performed for the&#xD;
      pancreaticojejunal anastomosis and the stent is placed from the pancreatic duct to the&#xD;
      jejunum.&#xD;
&#xD;
      The primary outcome of the study is the evaluation of the presence of POPF (drainage fluid&#xD;
      amylase value of &gt; 5000 U/L on the first day).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>POPF</measure>
    <time_frame>1 week</time_frame>
    <description>Evaluation of the presence of POPF (drainage fluid amylase value of &gt; 5000 U/L on the first day).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Position and degradation of biodegradable stents</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluation of the position and degradation time of the biodegradable stents</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pancreatic Fistula</condition>
  <condition>Pancreas Neoplasm</condition>
  <condition>Stent Disintegration</condition>
  <condition>Pancreatic Cancer</condition>
  <condition>Pancreatic Anastomotic Leak</condition>
  <arm_group>
    <arm_group_label>Biodegradable stent</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-biodegradable stent</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biodegradable stent</intervention_name>
    <description>Biodegradable stent (polymeric prostheses) is placed from the pancreatic duct to the jejunum. Duct-to-mucosa end-to-side anastomosis is performed for the pancreaticojejunal anastomosis.</description>
    <arm_group_label>Biodegradable stent</arm_group_label>
    <arm_group_label>Non-biodegradable stent</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cephalic pancreaticoduodenectomy (Whipple procedure).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing cephalic pancreaticoduodenectomy (Whipple procedure).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with soft pancreas or chronic pancreatitis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>David Ferreras</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Ferreras, MD</last_name>
      <phone>0034968369677</phone>
      <email>david_99db@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 2, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 7, 2021</last_update_submitted>
  <last_update_submitted_qc>March 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Virgen de la Arrixaca</investigator_affiliation>
    <investigator_full_name>David Ferreras</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pancreaticoduodenectomy</keyword>
  <keyword>pancreaticojejunostomy</keyword>
  <keyword>pancreatic stent</keyword>
  <keyword>pancreatic fistula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Anastomotic Leak</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

